Advisory Board

Steve Perry

Steve Perry is the CEO at GDF11 Rejuvenation and a biomarker activist in the industry and believes all anti-aging regimens should be required to show significant improvement in the “Big Four” biomarkers of blood pressure, pulse, heart rate variability, and reaction time.

Growth Differentiation Factor 11 (GDF11) is a naturally occurring peptide that has been cited in many papers as having an amazing capacity to restore aging muscles, hearts, brains, and immune systems in mice. It had never been tested in humans until Steve became patient zero on June 7, 2014.

Steve’s path to GDF11 research started at the University of Pennsylvania where he earned his Bachelor’s Degree of Science in Computer Science in 1980. Since then, Steve has founded and sold several software/tech companies including Revelation Technologies (a database company) in 1992, PowerPay Software (a payroll company) in 1998, and CorporateRewards (a web-based sales incentive company) in 2012.

After 40 years of tech/software development, Steve believes that all complex systems are highly programmed – if not, they fall into chaos quickly. The ultimate complex system, the human body, is highly programmed and aging is no exception. Steve believes that lifespan is programmed by natural selection based on a species’ resources, predation, and stability of their environment.

The main mechanism for determining lifespan is a naturally occurring, blood-born peptide called GDF11. Interestingly enough, the molecular structure of GDF11 is maintained across all vertebrate species. Everyone has GDF in them, but unless you are 18, you don’t have enough of it. Parabiosis strongly suggests that blood-borne peptides, especially GDF11, are a key component of aging. Steve founded GDF11 Rejuvenation in June 2014 to explore the efficacy of GDF11 supplementation.

Steve and his company have worked with hundreds of GDF11ers and developed a dosing methodology that titrates the GDF11 dose to the “Big Four” biomarkers of blood pressure, pulse, heart rate variability, and reaction time. Significant improvement in these simple biomarkers is almost always observed. Improvement in more sophisticated biomarkers such as naïve T cell count, augmentation pressure, C-reactive protein, intima-media thickness, etc. is also likely with GDF11 supplementation.

Read and watch the presentation at Results of exogenous GDF11 supplementation – the view of Patient Zero. View and listen to Steve’s presentation at Longevity 2020.

Watch Exploring GDF11 a Cytokine Key to Reversing Key Markers of Aging and Steve Perry presents GDF11 with an Age Reversal update by Bill Faloon. Watch Steve at the People Unlimited event.

Read Indication expansion to meet Longevity market demand. Read ME/CFS patient goes into remission after taking “elixir of youth” GDF11.

Visit his LinkedIn profile, Live Forever Club profile, and his Healthy Masters page.